Compare EP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EP | STIM |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.3M | 105.5M |
| IPO Year | N/A | 2018 |
| Metric | EP | STIM |
|---|---|---|
| Price | $3.57 | $1.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 62.7K | ★ 1.5M |
| Earning Date | 03-26-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $37,880,178.00 | ★ $129,873,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | N/A | $10.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $2.77 | $1.25 |
| 52 Week High | $6.90 | $5.92 |
| Indicator | EP | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 38.34 |
| Support Level | $2.80 | $2.02 |
| Resistance Level | $3.39 | $2.29 |
| Average True Range (ATR) | 0.28 | 0.21 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 29.00 | 14.73 |
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.